Medios AG, a leading European specialty pharma provider, has announced the appointment of Katrin Neuffer as Director Investor Relations & Communications, effective immediately. Neuffer will succeed Claudia Nickolaus, who has led the department for several years. The move comes as Medios prepares for a series of pivotal events in the 2026 financial year, underscoring the company's commitment to strengthening its capital markets presence.
Neuffer brings nearly two decades of experience in capital markets communications. She began her career at an investor relations agency and later served as Head of Investor Relations & Corporate Communications at SDAX-listed Wacker Neuson SE from 2007 to 2018, where she guided the company through its IPO and solidified its reputation as a consistently attractive investment. Her tenure there also included leadership roles in Strategy and Sustainability. Subsequently, she led an international team of 20 as Vice President Investor Relations & Corporate Communications and Marketing at the Exyte Group, where she was responsible for preparing an IPO targeted at a market capitalization exceeding EUR 2 billion. Since 2020, she has worked as an independent consultant, advising publicly listed companies on investor relations, IPO preparation, and crisis and restructuring communications.
Claudia Nickolaus, who is stepping down, played a key role in building Medios' investor relations activities, from financial reporting and ESG communications to the company's first Capital Markets Day in 2022. Prior to joining Medios, she held senior investor relations positions at publicly listed companies, including Merck KGaA.
Thomas Meier, CEO of Medios AG, expressed confidence in the new appointment: "With Katrin Neuffer, we are gaining a proven capital markets expert who has guided publicly listed companies through decisive phases of development, from IPOs to strategic repositioning. Her experience will help us reposition Medios in the capital markets and intensify our dialogue with investors, analysts, and the media. On behalf of the Company, I would like to express my sincere thanks to Claudia Nickolaus: Over many years, she shaped Medios' capital markets communications with tremendous dedication, a high level of professionalism, and personal reliability. She deserves our sincere gratitude for this."
Neuffer's appointment is effective immediately, and she will oversee communications with investors, analysts, the media, and the public. Her extensive background in IPO preparation and strategic communications is expected to be instrumental as Medios gears up for a series of critical events in the 2026 fiscal year. These include the Half-Year Financial Report on August 12, participation in the Berenberg and Goldman Sachs 15th German Corporate Conference in Munich from September 21 to 23, the Medios Capital Markets Day on September 28/29, and the Quarterly Statement on November 10. These events will be crucial for the company to communicate its strategy and performance under Neuffer's leadership.
Medios AG is Germany's first listed specialty pharmaceutical company, with shares traded on the regulated market of the Frankfurt Stock Exchange (Prime Standard) and included in the SDAX selection index. The company operates in Germany, the Netherlands, Belgium, and Spain, focusing on innovative solutions and intelligent services for the supply chain. Medios is dedicated to advancing individualized medicine to make innovative therapies accessible to all, in collaboration with pharmacies, specialist practices, and pharmaceutical companies.
For more information about Medios AG, visit www.medios.group. Details on individualized medicine are available at https://app.medios.group/en/individualizedmedicine.
This leadership change signals Medios' proactive approach to enhancing its investor relations and communications strategy, which is vital for maintaining transparency and trust with its stakeholders in the competitive specialty pharma market.
